Literature DB >> 15710227

Development of ADAMTS13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura.

Masato Yagita, Masahito Uemura, Takefumi Nakamura, Akane Kunitomi, Masanori Matsumoto, Yoshihiro Fujimura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710227     DOI: 10.1016/j.jhep.2004.08.030

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  12 in total

1.  46-year-old man with fatigue and brown urine.

Authors:  Michael A Mao; John R Hoyt; Mark A Nyman
Journal:  Mayo Clin Proc       Date:  2011-03       Impact factor: 7.616

Review 2.  Relevance of ADAMTS13 to liver transplantation and surgery.

Authors:  Saiho Ko; Hisanao Chisuwa; Masanori Matsumoto; Yoshihiro Fujimura; Eiji Okano; Yoshiyuki Nakajima
Journal:  World J Hepatol       Date:  2015-07-08

Review 3.  Pivotal role of ADAMTS13 function in liver diseases.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

4.  Dengue Virus Infection Triggering Thrombotic Thrombocytopenic Purpura in Pregnancy.

Authors:  Surendran Deepanjali; Raghuramulu R Naik; Sharada Mailankody; Sivamani Kalaimani; Tamilarasu Kadhiravan
Journal:  Am J Trop Med Hyg       Date:  2015-08-17       Impact factor: 2.345

5.  A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection.

Authors:  Fernanda C Rossi; Rodrigo N Angerami; Erich V de Paula; Fernanda L Orsi; Dezhi Shang; Vânia M del Guercio; Mariângela R Resende; Joyce M Annichino-Bizzacchi; Luiz J da Silva; X Long Zheng; Vagner Castro
Journal:  Transfusion       Date:  2009-09-24       Impact factor: 3.157

6.  Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure.

Authors:  Hiroaki Takaya; Hitoshi Yoshiji; Hideto Kawaratani; Kazuya Sakai; Masanori Matsumoto; Yoshihiro Fujimura; Hiroshi Fukui
Journal:  Biomed Rep       Date:  2017-07-19

7.  Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hepatol       Date:  2011-07-18

8.  Opana ER (Oxymorphone)-Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C.

Authors:  Hassan Mehmood; Muzammil Khan; Asghar Marwat; Medha Joshi; Varun Malhotra
Journal:  J Investig Med High Impact Case Rep       Date:  2018-01-31

9.  Thrombotic thrombocytopenic purpura (TTP)-like illness associated with intravenous Opana ER abuse--Tennessee, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-11       Impact factor: 17.586

10.  Thrombotic Thrombocytopenic Purpura in a Case of Dengue Fever: A Rare Presentation.

Authors:  Abhijit S Gavali; Jayant Shelgaonkar; Sandip Bartakke
Journal:  Indian J Crit Care Med       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.